Clinical trial
Verification Study on Lafutidine in Mild Reflux Oesophagitis - Double Blind…
NCT00229424 · Taiho Pharmaceutical Co., Ltd., Industry · Completed
Key facts
| NCT number | NCT00229424 |
|---|---|
| Title | Verification Study on Lafutidine in Mild Reflux Oesophagitis - Double Blind Controlled Study With Famotidine - |
| Official title | Verification Study on Lafutidine in Mild Reflux Oesophagitis - Double Blind Controlled Study With Famotidine - |
| Lead sponsor | Taiho Pharmaceutical Co., Ltd., Industry |
| Collaborators | UCB Pharma Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Gastroesophageal Reflux |
| Intervention type | Drug, Other |
| Interventions | Lafutidine, Famotidine, Placebo |
| Enrollment | 325 |
| Start date | Apr 1, 2005 |
| Primary completion | Oct 1, 2006 |
| Completion | Jan 1, 2007 |
| First posted | Sep 29, 2005 |
| Last update posted | Jul 7, 2011 |
| Countries | Japan |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: